New study offers clues on how to future-proof covid-19 vaccines

FHS
June 27, 2023
2:38 am

New research examining how frequently our bodies produce broadly neutralizing antibodies (bnAbs) capable of thwarting a range of SARS-CoV-2 variants offers clues on the strategy tweaks that could potentially future-proof COVID-19 vaccines.

MindMed’s Phase 2b Trial For MM-120 in GAD Reaches Enrollment Milestone

MindMed (NASDAQ: MNMD) (NEO: MMED), a clinical-stage biopharmaceutical company focused on pioneering innovative treatments for brain health disorders, made a noteworthy announcement today. They have

September 12, 2023

Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO

→ Preston Klassen has mapped out his next destination as president and R&D chief of microRNA developer Regulus Therapeutics. Klassen was the CEO of Metacrine,

June 17, 2023

Study highlights racial and ethnic disparities in disability among older adults

Roughly 40% of older Black adults live with a disability, compared to only one-third of older adults overall.

October 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.